Pharmaceutical 4376 articles

Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.

Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.

FDA chief nominee Califf faces tough opposition from senators


Dr. Robert Califf’s long-term, significant ties to the pharmaceutical industry prove he would be soft on drug companies pushing new opioid painkillers which, in turn, would worsen the country’s prescription drug abuse epidemic, and for this reason, Califf is unacceptable choice to head the Food and Drug Administration (FDA), said Sen. Joe Manchin, D-W.Va. in a written statement. Manchin added he would filibuster the nomination, using that time to read letters from West Virginia families affected by opioid abuse. Califf currently serves as the FDA’s deputy commissioner for medical products and tobacco. His 2014 financial disclosures revealed he had been ... Read More

Should our DNA be used for corporate profit? Human Rights Committee reviews future of Canadian genetic testing


According to CBC News thousands of Canadians are still opting out of genetic testing that could give them valuable information to possibly reduce risks for debilitating or life-threatening illnesses in their own lives, or knowledge that could inform their children’s medical futures. With Canada being the only G7 country with no form of protection against genetic discrimination, its citizens have reason to fear that such tests will be reported to insurance companies, raising premiums or hurting their chances of being eligible for coverage. In some cases, they fear employers requesting this information and that it might compromise their careers. A senate ... Read More

Diabetes drug study prompts change in what doctors prescribe


Three quarters of physicians say they are prescribing more of the type 2 diabetes drug Jardiance to their patients after news that the drug significantly reduced the risk of death in diabetic patients, according to an online poll conducted by Medscape Medical News. Jardiance, manufactured by Boehringer Ingelheim and Eli Lily and Co., is in a class of newer diabetes drugs known as SGLT2 inhibitors. Other brand-name drugs in this class include Invokana and Invokamet, both made by Johnson & Johnson subsidiary Janssen Pharmaceuticals. The poll was prompted by a study published last fall in the New England Journal of ... Read More

Johnson and Johnson fights to keep Cherokee Nation’s Risperdal case in federal court


Johnson & Johnson and its subsidiary Janssen Pharmaceuticals are asking an Oklahoma federal judge to keep in federal court a lawsuit filed against the companies by the Cherokee Nation over undisclosed side effects with its antipsychotic drug Risperdal. The drug companies claim that the rightful plaintiff in the case is not the Cherokee Nation, but a holding company for the tribal businesses, and that the case should remain in federal court on diversity grounds. The Cherokee Nation originally filed the lawsuit in April 2015 in Oklahoma’s Sequoyah County Court seeking restitution for Risperdal the tribe had purchased under the impression ... Read More

Feds find dangerous, unlisted drug ingredients in OTC diet pills

bathroom scale

Lucy’s Weight Loss System of Arlington, Texas, has expanded its recall of diet pills to include all lots of Pink Bikini and Shorts on the Beach capsules in all colors, 30 count, after an analysis found the products to contain potentially dangerous undeclared drug ingredients. Pink Bikini (white capsules, blue capsules and gold capsules) and Shorts of the Beach (blue capsules and gold capsules) were found to contain sibutramine, phenolphthalein and/or diclofenac, which were not listed on the products’ labels. Sibutramine is an appetite suppressant that was sold under the brand name Meridia and pulled from the U.S. market in ... Read More

Common drugs that doctors refuse to take


Just because a medication is approved by the Food and Drug Administration (FDA) does not mean it is safe. In fact, many drugs have been linked to concerning side effects. That’s why it is important for patients to weigh the risks and benefits of all drugs before taking them, including seemingly innocuous over-the-counter medicines. Men’s Health magazine compiled a list of medications that doctors said they wouldn’t take themselves. If you or someone you love is taking any of these, it might be time to discuss your risk with a doctor. Pseudoephedrine – The decongestant that is used to manufacture ... Read More

Diabetic test strips recalled due to false readings


About 2,500 diabetic test strips used specifically by health care providers are being recalled because they may report falsely low blood glucose levels. Because the tests trips are reporting falsely low blood glucose when the true levels are above 265 mg/dL, there is a risk that the health care provider would not diagnose hyperglycemia (high blood sugar) including diabetic ketoacidosis and hyperosmolar hyperglysemic syndrome in a timely manner and fail to treat elevated blood glucose levels. The recall involves the SPOTCHEM II Basic PANEL-1 Reagent Test Strips and SPOTCHEM II Glucose Reagent Test Strips, manufactured by Arkray Factory Inc., with ... Read More

Talc cases consolidated for multi-county litigation in New Jersey

baby powder contains talc

Since 2014 more than 100 talcum powder lawsuits have been brought against Johnson and Johnson and its subsidiaries in Atlantic and Bergen counties in New Jersey. In November 2015, the New Jersey Supreme Court approved them for multi-county litigation status. Judge Julio L. Mendez and Judge Nelson C. Johnson of the Atlantic County Superior Court have been assigned jurisdiction over the centralized management of the these cases. According to Law360, Johnson and Johnson requested the consolidation of the cases. “While each plaintiff will have an individualized medical history, alleged exposure history and unique facts, each of the complaints contains consistent allegations ... Read More

Two men fight statute of limitations ruling in Risperdal gynecomastia cases


Two men who claim they developed breasts after taking the antipsychotic Risperdal as adolescents are asking a Philadelphia appeals court to undo a judge’s ruling to dismiss their lawsuits and more than 250 others against the manufacturer of the drug because they waited too long to file their lawsuits. Joshua Winter and Jonathan Saksek told the Philadelphia Superior Court that the judge was in error when he surmised that the plaintiffs should have known the link between Risperdal and breast growth by 2009. The men said that a jury should decide when media reports and other sources would have provided enough ... Read More

Pharmacists plead guilty for compounded drugs linked to patient deaths


Two Alabama pharmacists who compounded drugs contaminated with bacteria that were linked to nine deaths have agreed to plead guilty to charges of drug adulteration, according to the U.S. Department of Justice. David Lee Allen and William Timothy Rogers, both pharmacists with the now shuttered Meds IV, could spend up to two years in prison, though prosecutors have agreed to recommend lighter sentences. Rogers also served as the president of Meds IV. The pharmacy made an intravenous amino acid dietary solution called total parenteral nutrition, or TPN, which was shipped to hospitals and administered to patients. Some patients developed bloodstream ... Read More